CHENGDU HUASUN TECHNOLOGY GROUP INC. , LTD.

Chengdu huasun technology group Inc. , LTD.

000790

CNE0000001H5

Pharmaceuticals

End-of-day quote Shenzhen S.E. Other stock markets 06:00:00 2024-07-02 pm EDT			5-day change	1st Jan Change
3.56 ^CNY	-0.56%		+2.01%	-29.64%

May. 30	Chengdu huasun technology group Inc. , LTD. Approves 2023 Profit Distribution Plan	CI
May. 03	Huasun Technology to Cancel 3.8 Million Repurchased Shares	MT

Chengdu Huasun Group Inc.,Ltd. Approves Dismissal of Zuo Xiaojun as Director

September 10, 2013 at 06:28 am EDT

Chengdu Huasun Group Inc.,Ltd. held Extraordinary General Meeting on 09 September 2013. At the meeting the shareholders approved dismissal of Zuo Xiaojun as director.

Latest news about Chengdu huasun technology group Inc. , LTD.

Chengdu huasun technology group Inc. , LTD. Approves 2023 Profit Distribution Plan	May. 30	CI
Huasun Technology to Cancel 3.8 Million Repurchased Shares	May. 03	MT
Chengdu Huasun Technology Group Inc. , Ltd. Announces Cash Profit Distribution Proposal for 2023	Apr. 29	CI
Chengdu huasun technology group Inc. , LTD. Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 29	CI
Chengdu huasun technology group Inc. , LTD. Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 29	CI
Chengdu Huasun Technology to Construct Drug Ingredient Plant for 480 Million Yuan	Nov. 07	MT
Chengdu huasun technology group Inc. , LTD. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-30	CI
Chengdu huasun technology group Inc. , LTD. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-29	CI
Chengdu Huasun Technology to Buy 51% of Local Peer for 51 Million Yuan; Shares Jump 3%	23-08-08	MT
Chengdu huasun technology group Inc. , LTD. singed a Share Transfer Agreement to acquire a 51% stake in Tibet Kangyu Pharmaceutical Co., Ltd. from Tibet Wan?an Drug Information Consulting Co., Ltd. for CNY 51 million.	23-08-07	CI
Chengdu Huasun Technology Group Inc. , Ltd. Elects Chen Xudong and Zhu Chaoxi as Independent Directors; and Zhu Ying as Non-Employee Supervisor	23-07-28	CI
Chengdu huasun technology group Inc. , LTD. agreed to acquire Sichuan Bohaoda Biotechnology Co., Ltd. from Sichuan Yuanhong Biotechnology Co., Ltd. and Chengdu Bohaoda Biotechnology Co., Ltd for CNY 1 billion.	23-06-20	CI
Chengdu huasun technology group Inc. , LTD. announced that it expects to receive funding from Chengdu Yuanhong Biological Technology Co., Ltd., and other investors	23-06-19	CI
Chengdu Huasun Technology Group Inc. , Ltd. Announces Final Dividend on Share A for 2022, Payable on June 13, 2023	23-06-07	CI
Chengdu huasun technology group Inc. , LTD. Approves Profit Distribution Proposal for 2022	23-05-24	CI
Chengdu huasun technology group Inc. , LTD. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-27	CI
Chengdu Huasun Technology Group Inc., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-27	CI
Chengdu Huasun Technology to Invest $28 Million in Pharmaceutical Firm	22-09-30	MT
Chengdu Huasun Technology Group Inc., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-30	CI
Chengdu Huasun Technology Group Inc., Ltd. Announces Final Cash Dividend on A Shares for 2021, Payable on July 14, 2022	22-07-06	CI
Chengdu Huasun Technology Group Inc., Ltd. Approves Cash Dividend for the Year 2021	22-05-25	CI
Chengdu Huasun Technology Group Inc., Ltd. announced that it expects to receive CNY 399.999998 million in funding from Chengdu Yuanhong Biological Technology Co., Ltd.	22-05-19	CI
Chengdu Huasun Technology Group Inc., Ltd. Announces Profit Distribution Proposal for 2021	22-05-05	CI
Chengdu Huasun Technology Group Inc., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-29	CI
Chengdu Huasun Technology Group Inc., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	22-04-29	CI

Chart Chengdu huasun technology group Inc. , LTD.

Duration

Period

Chart Chengdu huasun technology group Inc. , LTD.

More charts

Chengdu Huasun Technology Group Co Ltd, formerly Chengdu Taihe Health Technology Group Inc., Ltd., is principally engaged in manufacture and distribution of Chinese medicines and Western medicines, fabrication and installation services of steel structures, as well as production and sale of bio-engineering products. The Company primarily provides Chinese medicines, Western medicines, biological drugs, veterinary drugs and veterinary biological vaccines, as well as modern steel structures. Its pharmaceutical products include oral liquid, capsules, biological products and veterinary drugs, among others. The Company operates its businesses primarily in the China domestic market, with Sichuan province as its main market.

Sector

Pharmaceuticals

Calendar

2024-08-21 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

	1st Jan change	Capi.
CHENGDU HUASUN TECHNOLOGY GROUP INC. , LTD.	-29.64%	308M
ELI LILLY AND COMPANY	+54.07%	809B
NOVO NORDISK A/S	+39.46%	621B
JOHNSON & JOHNSON	-7.05%	351B
MERCK & CO., INC.	+15.44%	319B
ABBVIE INC.	+5.72%	289B
ASTRAZENECA PLC	+14.79%	238B
ROCHE HOLDING AG	-0.45%	221B
NOVARTIS AG	+14.65%	218B
AMGEN INC.	+7.42%	166B